HDFC Mid Cap Fund Regular-Growth
The fund is rated 4.5 stars. The strongest areas were investment selection within each asset type and investment selection within each industry, while balance between returns and downside risk provided some support. Above-average fund size of Rs 105,142.69 crore was a minor drawback.
This fund has a good track record with Asset Selection/Timing, a good track record with Stock Selection/Timing. It is important to note, however, that this fund has a 105142.694 AUM and a 1.3 expense ratio. Considering all these factors, we have rated this fund as 4.5 star.
எங்கள் score நீண்டகால performance, risk மற்றும் consistency-ஐ மதிப்பிடுகிறது — past returns மட்டும் அல்ல.
Returns
25 Sep 2026 நிலவரப்படி
Risk ratios
31 Aug 2026 நிலவரப்படி
Portfolio
31 Aug 2026 நிலவரப்படி
Market-cap பிரிவு
துறை ஒதுக்கீடு
Holdings (80)
| Holding | Fund-இன் % | மதிப்பு | பங்குகள் |
|---|---|---|---|
| Others | 6.91% | ₹7,484.03 Cr | — |
| The Federal Bank Ltd. | 4.21% | ₹4,559.52 Cr | 12,78,25,000 |
| AU Small Finance Bank Ltd. | 3.98% | ₹4,316.27 Cr | 3,97,37,347 |
| Max Financial Services Ltd. | 3.79% | ₹4,108.03 Cr | 2,61,14,231 |
| Ipca Laboratories Ltd. | 3.30% | ₹3,575.69 Cr | 1,81,05,658 |
| Glenmark Pharmaceuticals Ltd. | 3.07% | ₹3,325.23 Cr | 1,34,08,183 |
| Indian Bank | 3.06% | ₹3,312.3 Cr | 3,68,54,482 |
| Balkrishna Industries Ltd. | 3.02% | ₹3,268.66 Cr | 1,43,41,251 |
| Coforge Ltd. | 2.86% | ₹3,101.16 Cr | 1,56,20,600 |
| Fortis Healthcare Ltd. | 2.69% | ₹2,911.32 Cr | 3,21,01,862 |
Fund விவரங்கள்
to generate long-term capital appreciation / income. investment predominantly in Mid-Cap companies.
The scheme seeks to provide long-term capital appreciation/income by investing predominantly in Mid-Cap companies.
Exit load of 1% if redeemed within 1 year.